Clinical trials
Phase 2 Multiple Sclerosis, Relapsing-Remitting trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Tanabe Pharma Corporation | 2 |
| Clene Nanomedicine | 1 |
| Genentech, Inc. | 1 |
| Grifols Therapeutics LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Sanofi | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 15 |
| Multiple Sclerosis | 7 |
| Demyelinating Diseases | 3 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Neuritis | 1 |
| Neuromyelitis Optica | 1 |
| Optic Nerve Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.